mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.2 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
0.16 |
0.2 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.039 |
0.2 |